Literature DB >> 31290070

Bacteroides in colonic mucosa-associated microbiota affects the development of minimal hepatic encephalopathy in patients with cirrhosis.

Masafumi Haraguchi1, Satoshi Miuma2, Hiroshi Masumoto3, Tatsuki Ichikawa4, Yasuko Kanda1, Ryu Sasaki1, Masanori Fukushima1, Hisamitsu Miyaaki1, Naota Taura1, Kazuhiko Nakao1.   

Abstract

BACKGROUND/
PURPOSE: Gut microbiota has been associated with liver cirrhosis and, possibly, hepatic encephalopathy. However, only a few studies have examined the link between mucosa-associated microbiota (MAM) and minimal hepatic encephalopathy (MHE). Our aim was to investigate this relationship.
METHODS: Twenty-four patients with cirrhosis underwent colon biopsies at our institution, between January 2014 and April 2015. Patterns of microbial colonization were examined using 16S rRNA gene sequences. MHE was diagnosed using the Neuropsychological Test.
RESULTS: Ten (41.7%) of the 24 patients were diagnosed as having MHE. There was no significant difference in the diversity of gut microbiota by sampling locations between those with and without MHE. However, the diversity of the gut microbiota and the proportion of the genus Bacteroides decreased as a function of declining liver function. We divided patients into those with the highest proportion of the genus Bacteroides (Bacteroides-dominant group; n = 9) and into a Bacteroides non-dominant group (n = 15). In the Bacteroides-dominant group, only 1 patient (11.1%) was diagnosed as having MHE, with the incidence rate of MHE being significantly lower in the Bacteroides-dominant group than in the non-dominant group (p = 0.019). The Child-Pugh score (p = 0.05) and use of proton-pump inhibitors (p = 0.015) were negatively correlated to the proportion of Bacteroides. Furthermore, the proportion of the family Clostridiaceae was significantly higher in the Bacteroides-dominant group than in the non-dominant group (p = 0.078).
CONCLUSIONS: The decrease in microbial diversity and genus Bacteroides in MAM is a risk factor for MHE in patients with liver cirrhosis.

Entities:  

Keywords:  Cirrhosis; Microbiota; Minimal hepatic encephalopathy; Next-generation sequencing

Mesh:

Year:  2019        PMID: 31290070     DOI: 10.1007/s12072-019-09963-2

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  2 in total

Review 1.  The Role of Intestinal Bacteria and Gut-Brain Axis in Hepatic Encephalopathy.

Authors:  Zefeng Chen; Jingsheng Ruan; Dinghua Li; Min Wang; Zhiwei Han; Wenxia Qiu; Guobin Wu
Journal:  Front Cell Infect Microbiol       Date:  2021-01-21       Impact factor: 5.293

2.  Comparative study of the effect of neuromuscular electrical stimulation and oral administration of branched-chain amino acid on preventing sarcopenia in patients after living-donor liver transplantation: study protocol for an open-label randomized controlled trial.

Authors:  Masafumi Haraguchi; Kunihiro Ichinose; Hisamitsu Miyaaki; Masatoshi Hanada; Masanori Fukushima; Ryu Sasaki; Satoshi Miuma; Takanobu Hara; Tota Kugiyama; Akihiko Soyama; Masaaki Hidaka; Ayumi Tsuji; Rintaro Yano; Motohiro Sekino; Hideaki Takahata; Susumu Eguchi; Kazuhiko Nakao
Journal:  Trials       Date:  2021-02-12       Impact factor: 2.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.